Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

Creative Commons License

Gemcioglu E., Davutoglu M., Catalbas R., Karabuga B., Kaptan E., Aypak A., ...More

Future Virology, vol.16, no.5, pp.353-367, 2021 (Journal Indexed in SCI Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 5
  • Publication Date: 2021
  • Doi Number: 10.2217/fvl-2020-0319
  • Title of Journal : Future Virology
  • Page Numbers: pp.353-367
  • Keywords: biomarkers, blood urea nitrogen/albumin ratio, co-morbidity-age-lymphocyte-LDH score, COVID-19, neutrophil/albumin ratio, predictive value of tests, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2


© 2021 Future Medicine Ltd.. All rights reserved.Aim: COVID-19 is a pandemic that causes high morbidity and mortality, especially in severe patients. In this study, we aimed to search and explain the relationship between biochemical markers, which are more common, easily available and applicable to diagnose and to stage the disease. Materials and methods: In this study, 609 patients were evaluated retrospectively. 11 biochemical parameters were included in analysis to explain the relationship with severity of disease. Results: Nearly, all the parameters that have been evaluated in this study were statistically valuable as a predictive parameter for severe disease. Areas under the curve of blood urea nitrogen (BUN)/albumin ratio (BAR), CALL score and lymphocyte/C-reactive protein ratio were 0.795, 0.778 and 0.770. The BAR and neutrophil/albumin ratios provide important prognostic information for decision-making in severe patients with COVID-19. Conclusion: High BAR and neutrophil/albumin ratios may be a better predictor of severity COVID-19 than other routinely used parameters in admission.